Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In COPSAC2010, higher vitamin D blood levels at 1 week postpartum were associated with distinct maternal metabolome perturbations with significant enrichment of the sphingomyelin pathway (P < .01).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Double-blind reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The COPSAC2010 cohort study is a mother-child cohort with 736 participating families.

Source: Methods.

A subset of pregnant women (n = 623) was enrolled in a double-blinded randomized controlled trial (RCT) at pregnancy week 24, where they were randomized 1:1 to a daily dose of 2400 IU/day of vitamin D3 supplementation or a matching placebo tablet (Camette A/S, Syddanmark, Denmark) until 1 week postpartum ( identifier ).

Source: Methods.

Additionally, all women were given 400 IU/day of vitamin D3 supplementation during pregnancy as recommended by the Danish National Board of Health.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Maternal vitamin D-related metabolome and offspring risk of asthma outcomes

Cohort study · The Journal of allergy and clinical immunology · 2023

Original publication title

Maternal vitamin D: related metabolome and offspring risk of asthma outcomes

Min Kim; Nicklas Brustad; Mina Ali; Gözde Gürdeniz; Morten Arendt; Augusto A. Litonjua; Craig E. Wheelock; Rachel S. Kelly; Yulu Chen; Nicole Prince; Feng Guo; Xiaobo Zhou; Jakob Stokholm; Klaus Bønnelykke; Scott T. Weiss; Hans Bisgaard; Jessica Lasky-Su; Bo Chawes

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This exploratory metabolomics study in 2 independent birth cohorts demonstrates that the beneficial effect of higher gestational vitamin D exposure on offspring respiratory health is characterized by specific maternal metabolic alterations during pregnancy, which involves the sphingomyelin pathway.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

We sought to study the link between gestational vitamin D exposure and childhood asthma phenotypes using maternal blood metabolomics profiling.

Source: Objective:

Abstract: What methods does the paper describe?

Untargeted blood metabolic profiles were acquired using liquid chromatography-mass spectrometry at 1 week postpartum from 672 women in the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) mother-child cohort and at pregnancy weeks 32 to 38 from 779 women in the Vitamin D Antenatal Asthma Reduction Trial (VDAART) mother-child cohort. In COPSAC2010, we employed multivariate models and pathway enrichment analysis to identify metabolites and pathways associated with gestational vitamin D blood levels and investigated their relationship with development of asthma phenotypes in early childhood.

The findings were validated in VDAART and in cellular models.

Source: Methods:

Abstract: Results

In COPSAC2010, higher vitamin D blood levels at 1 week postpartum were associated with distinct maternal metabolome perturbations with significant enrichment of the sphingomyelin pathway (P < .01). This vitamin D: related maternal metabolic profile at 1 week postpartum containing 46 metabolites was associated with decreased risk of recurrent wheeze (hazard ratio [HR] = 0.92 [95% CI 0.86 to 0.98], P = .01) and wheeze exacerbations (HR = 0.90 [95% CI 0.84 to 0.97], P = .01) at ages 0 to 3 years.

The same metabolic profile was similarly associated with decreased risk of asthma/wheeze at ages 0 to 3 in VDAART (odds ratio = 0.92 [95% CI 0.85 to 0.99], P = .04). Human bronchial epithelial cells treated with high-dose vitamin D3 showed an increased cytoplasmic sphingolipid level (P < .01).

Source: Results:

Abstract: Conclusions

This exploratory metabolomics study in 2 independent birth cohorts demonstrates that the beneficial effect of higher gestational vitamin D exposure on offspring respiratory health is characterized by specific maternal metabolic alterations during pregnancy, which involves the sphingomyelin pathway.

Source: Conclusions:
Authors’ abstract

Background:

Gestational vitamin D deficiency is implicated in development of respiratory diseases in offspring, but the mechanism underlying this relationship is unknown.

Objective:

We sought to study the link between gestational vitamin D exposure and childhood asthma phenotypes using maternal blood metabolomics profiling.

Methods:

Untargeted blood metabolic profiles were acquired using liquid chromatography-mass spectrometry at 1 week postpartum from 672 women in the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) mother-child cohort and at pregnancy weeks 32 to 38 from 779 women in the Vitamin D Antenatal Asthma Reduction Trial (VDAART) mother-child cohort. In COPSAC2010, we employed multivariate models and pathway enrichment analysis to identify metabolites and pathways associated with gestational vitamin D blood levels and investigated their relationship with development of asthma phenotypes in early childhood.

The findings were validated in VDAART and in cellular models.

Results:

In COPSAC2010, higher vitamin D blood levels at 1 week postpartum were associated with distinct maternal metabolome perturbations with significant enrichment of the sphingomyelin pathway (P < .01). This vitamin D: related maternal metabolic profile at 1 week postpartum containing 46 metabolites was associated with decreased risk of recurrent wheeze (hazard ratio [HR] = 0.92 [95% CI 0.86 to 0.98], P = .01) and wheeze exacerbations (HR = 0.90 [95% CI 0.84 to 0.97], P = .01) at ages 0 to 3 years.

The same metabolic profile was similarly associated with decreased risk of asthma/wheeze at ages 0 to 3 in VDAART (odds ratio = 0.92 [95% CI 0.85 to 0.99], P = .04). Human bronchial epithelial cells treated with high-dose vitamin D3 showed an increased cytoplasmic sphingolipid level (P < .01).

Conclusions:

This exploratory metabolomics study in 2 independent birth cohorts demonstrates that the beneficial effect of higher gestational vitamin D exposure on offspring respiratory health is characterized by specific maternal metabolic alterations during pregnancy, which involves the sphingomyelin pathway.

Publication and source details

Original title: Maternal vitamin D: related metabolome and offspring risk of asthma outcomes

Min Kim; Nicklas Brustad; Mina Ali; Gözde Gürdeniz; Morten Arendt; Augusto A. Litonjua; Craig E. Wheelock; Rachel S. Kelly; Yulu Chen; Nicole Prince; Feng Guo; Xiaobo Zhou; Jakob Stokholm; Klaus Bønnelykke; Scott T. Weiss; Hans Bisgaard; Jessica Lasky-Su; Bo Chawes

The Journal of allergy and clinical immunology · 2023

*

These authors contributed equally to this work.

†

Dr Bisgaard died September 8, 2022.

Corresponding author: Bo Chawes, MD, PhD, DMSc, Copenhagen Prospective Studies on Asthma in Childhood, Ledreborg Allé 34, DK 2820 Gentofte, Copenhagen, Denmark. chawes@copsac.com.
https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:45:44.778047+00:00

DOI: 10.1016/j.jaci.2023.06.030 · PMC11147137